lamotrigine has been researched along with eslicarbazepine acetate in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 3 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Almeida, L; Brunet, JS; Falcão, A; Lefebvre, M; Nunes, T; Rocha, JF; Sicard, E; Soares-da-Silva, P | 1 |
| Baftiu, A; Brodtkorb, E; Burns, ML; Dinarevic, J; Johannessen Landmark, C; Johannessen, SI; Kufaas, RF; Reimers, A; Svendsen, T | 1 |
| Abou-Khalil, B; Blum, D; Cheng, H; Gama, H; Grinnell, T; Jung, J; Klein, P; Rocha, F; Ryvlin, P; Shah, A; Specchio, LM | 1 |
| Bialer, M; Franco, V; Odi, R; Perucca, E | 1 |
| Blum, D; Cantu, D; Gidal, B; Grinnell, T; Hixson, J; Mehta, D; Pikalov, A; Zhang, Y | 1 |
| Aboumatar, S; Cantu, D; Grinnell, T; Krishnaiengar, SR; Zhang, Y | 1 |
1 review(s) available for lamotrigine and eslicarbazepine acetate
| Article | Year |
|---|---|
Bioequivalence and switchability of generic antiseizure medications (ASMs): A re-appraisal based on analysis of generic ASM products approved in Europe.
Topics: Anticonvulsants; Area Under Curve; Biological Variation, Individual; Dibenzazepines; Drug Substitution; Drugs, Generic; Europe; Gabapentin; Humans; Lacosamide; Lamotrigine; Levetiracetam; Oxcarbazepine; Pregabalin; Therapeutic Equivalency; Topiramate; Vigabatrin; Zonisamide | 2021 |
4 trial(s) available for lamotrigine and eslicarbazepine acetate
| Article | Year |
|---|---|
Pharmacokinetic interaction study between eslicarbazepine acetate and lamotrigine in healthy subjects.
Topics: Administration, Oral; Adolescent; Adult; Anticonvulsants; Area Under Curve; Dibenzazepines; Drug Interactions; Drug Therapy, Combination; Epilepsy; Humans; Lamotrigine; Male; Middle Aged; Triazines; Young Adult | 2010 |
Tolerability of adjunctive eslicarbazepine acetate according to concomitant lamotrigine or carbamazepine use: A subgroup analysis of three phase III trials in adults with focal (partial-onset) seizures.
Topics: Adolescent; Adult; Anticonvulsants; Carbamazepine; Child; Dibenzazepines; Diplopia; Dose-Response Relationship, Drug; Double-Blind Method; Female; Follow-Up Studies; Humans; Lamotrigine; Male; Randomized Controlled Trials as Topic; Seizures; Vomiting; Young Adult | 2018 |
Efficacy and safety of eslicarbazepine acetate as a first or later adjunctive therapy in patients with focal seizures.
Topics: Anticonvulsants; Dibenzazepines; Double-Blind Method; Humans; Lamotrigine; Levetiracetam; Quality of Life; Seizures; Treatment Outcome | 2021 |
Time to baseline seizure count in patients with focal seizures receiving adjunctive eslicarbazepine acetate in a phase IV clinical trial.
Topics: Adult; Anticonvulsants; Dibenzazepines; Double-Blind Method; Humans; Lamotrigine; Levetiracetam; Seizures; Treatment Outcome | 2023 |
1 other study(ies) available for lamotrigine and eslicarbazepine acetate
| Article | Year |
|---|---|
The Impact of Pharmacokinetic Interactions With Eslicarbazepine Acetate Versus Oxcarbazepine and Carbamazepine in Clinical Practice.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Dibenzazepines; Drug Interactions; Drug Monitoring; Female; Humans; Infant; Infant, Newborn; Lamotrigine; Male; Middle Aged; Norway; Oxcarbazepine; Triazines; Valproic Acid; Young Adult | 2016 |